https://ctv.veeva.com/study/pharmacokinetic-profile-of-neupro-patch-administrated-at-2-mg-4-mg-6-mg-and-8-mg-day-weekly-in-pat
Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in...
To study the profile of Neupro patch administrated at 2 mg, 4 mg, 6 mg and 8 mg/day weekly in patients with early-stage Parkinson's disease
pharmacokinetic profileneupropatchmgday
https://pure.ug.edu.gh/en/publications/correction-to-pharmacokinetic-profile-of-amodiaquine-and-its-acti/fingerprints/?sortBy=alphabetically
Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine...
pharmacokinetic profilecorrectionactivemetabolite
https://www.page-meeting.org/Abstracts/pharmacokinetic-profile-of-sultiame-in-healthy-volunteers-with-in-vitro-characterization-of-its-uptake-by-red-blood-cells/
Pharmacokinetic Profile of Sultiame in Healthy Volunteers with In Vitro Characterization of Its...
Oct 21, 2025 - Poster: Drug/Disease modelling - CNS - Pharmacokinetic Profile of Sultiame in Healthy Volunteers with In Vitro Characterization of Its Uptake by Red Blood Cells
pharmacokinetic profilehealthy volunteersvitrocharacterization
https://www.pharmatutor.org/magazines/articles/december-2015/study-effect-supplementation-zingiber-officinale-pharmacokinetic-profile-sitagliptin-phosphate
Study of Effect of supplementation of Zingiber Officinale on pharmacokinetic profile of Sitagliptin...
zingiber officinalepharmacokinetic profilestudyeffectsupplementation
https://eatris.cz/publication/impact-factor-journals/modulating-pharmacokinetic-profile-actinium-225-labeled-macropa?language=en&language_content_entity=en
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by...
pharmacokinetic profilemodulatingactiniumlabeledderived
https://sportsz.news/news/nanexa-announces-breakthrough-preclinical-data-demonstrating-exceptional-pharmacokinetic-profile-for-monthly-semaglutide-formulation/
Nanexa Announces Breakthrough Preclinical Data Demonstrating Exceptional Pharmacokinetic Profile...
Jan 27, 2026 - Stay updated with the latest sports news, live scores, match highlights, sports news today, and expert analysis from around the world.
pharmacokinetic profileannouncesbreakthroughpreclinicaldata
https://pmc.ncbi.nlm.nih.gov/articles/PMC6676961/
Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid - PMC
Currently, an unprecedented number of individuals can legally access cannabis. Vaporization is increasingly popular as a method to self-administer cannabis,...
pharmacokinetic profilehuman bloodacutesmokedvaporized
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247546
Pharmacokinetic profile of injectable tramadol in the koala (Phascolarctos cinereus) and prediction...
Tramadol is used as an analgesic in humans and some animal species. When tramadol is administered to most species it undergoes metabolism to its main...
pharmacokinetic profileinjectabletramadolkoalaprediction
https://kubanni.abu.edu.ng/items/3b64ef94-9f44-4be0-8afe-d4819c125b4f/full
THE INFLUENCE OF METRONIDAZOLE ON THE PHARMACOKINETIC PROFILE OF CHLORPROPAMIDE IN TYPE II DIABETIC...
The influence of metronidazole on the pharmacokinetic profile of chlorpropamide in Type II diabetic patients was examined. The quality of chlorpropamide and...
the influencepharmacokinetic profiletype iimetronidazolechlorpropamide
https://www.natap.org/2024/CROI/croi_163.htm
A Shape-Shifting Tail Decay is the Pharmacokinetic Profile of an Ultra-Long Acting Bictegravir...
shape shiftingpharmacokinetic profilelong actingtaildecay
https://www.iris.uniroma5.it/handle/20.500.12078/821
L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release...
l dopapharmacokinetic profileeffervescentversusstandard
https://www.certara.com/publication/pharmacokinetic-profile-of-defibrotide-in-patients-with-renal-impairment/
Pharmacokinetic Profile of Defibrotide in Patients with Renal Impairment | Certara
Jun 4, 2025 - Hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome (VOD/SOS), is an unpredictable, potentially life-threatening complication of
pharmacokinetic profilepatientsrenalimpairment